Related Experiment Video
Updated: May 20, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
A primer on the epigenetics of kidney fibrosis
1Department of Nephrology and Rheumatology, Göttingen University Medical Center, Georg August University, Göttingen, Germany.
Abstract:
Despite extensive knowledge of the various molecular pathways that contribute to tubulointerstitial fibrosis, it remains an unsolved question why the progression rate of chronic kidney disease varies substantially from patient to patient, even among patients with common underlying nephropathies and comorbidities. Possible explanations for different susceptibilities of individual patients to develop end-stage renal failure include genetic or epigenetic variations, which modify how individual patients respond to kidney injury. Here we review principles of epigenetic mechanisms in context of chronic kidney disease and discuss how such insights may be utilized for future therapeutic strategies and may lead to novel diagnostic tools in the future.
Insights
Epigenetic variations may explain why chronic kidney disease progresses differently in patients. Understanding these epigenetic mechanisms could lead to new diagnostic tools and therapies for kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Tubulointerstitial fibrosis is a key factor in chronic kidney disease (CKD) progression.
- The rate of CKD progression varies significantly among patients, even with similar conditions.
- Genetic and epigenetic factors are suspected to influence individual patient susceptibility to kidney injury.
Purpose of the Study:
- To review the principles of epigenetic mechanisms in the context of CKD.
- To explore how epigenetic insights can inform future therapeutic strategies for CKD.
- To discuss the potential of epigenetics in developing novel diagnostic tools for kidney disease.
Main Methods:
- Literature review of epigenetic mechanisms.
- Analysis of existing research on CKD progression and patient variability.
- Synthesis of findings to connect epigenetics with CKD pathogenesis and clinical application.
Main Results:
- Epigenetic modifications (e.g., DNA methylation, histone modification) can alter gene expression without changing DNA sequence.
- These modifications can influence cellular responses to kidney injury, contributing to fibrosis.
- Individual epigenetic profiles may underlie differential susceptibility to CKD progression.
Conclusions:
- Epigenetic mechanisms play a crucial role in the variable progression of chronic kidney disease.
- Targeting epigenetic pathways offers potential for novel therapeutic interventions.
- Epigenetic markers may serve as valuable diagnostic or prognostic tools for CKD patients.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Nephrotic Syndrome I : Introduction
Nephrons
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

